Organization · Private Equity

Witruth Capital

Witruth Capital is a private equity investment firm based in China, focusing on the Chinese primary capital market and investment banking. The firm has been active for over 12 years, engaging in various sectors including technology and biomedicine.

Private EquityFunder

Overview

What Witruth Capital does

What Witruth Capital is

Witruth Capital is a private equity investment firm based in China, focusing on the Chinese primary capital market and investment banking. The firm has been active for over 12 years, engaging in various sectors including technology and biomedicine.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Private Equity
Founded
Founded in 2012
Approximate age
About 14 years
Structured capabilities
Funder
Last reviewed
March 4, 2026

Official channels

Find Witruth Capital elsewhere

Open the official website or a supported primary organization account.

Capability profile

Witruth Capital as a funder

Investment thesis

Witruth Capital aims to leverage its extensive experience in finance and investment to identify and support promising companies in the TMT and biomedicine sectors within China. The firm focuses on both early-stage and later-stage investments.

Focus narrative

Witruth Capital operates through three main platforms: Investment Banking, Private Equity Investment, and Financial Technology. The firm has set up four equity investment funds with a total available fund size of nearly 300 million RMB. For early-stage investments, the typical project investment size is around 10 million RMB, while for later-stage investments, it is approximately 30 million RMB.

Terms and economics

Typical check
$1,430,000–$4,290,000

Focus and fit

Stages
Pre-seed · Seed · Seed+ · Series A · Series B · Series C
Regions
AsiaChina

Availability

Currently deploying
Not published

Portfolio and track record

Portfolio context

Witruth Capital has invested in various companies across different sectors, particularly in TMT and biomedicine. Specific notable portfolio companies were not detailed in the provided content.

Connected ecosystem

Continue from Witruth Capital

These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.

Common questions

What to know about Witruth Capital

Upseed classifies Witruth Capital under the Private Equity organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

March 4, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.